Clinical implications of microRNAs in lung cancer

Seminars in Oncology

Volumn 38, Issue 6, 2011, Pages 776-780

  Fanini, Francesca ^a   Vannini, Ivan ^a   Amadori, Dino ^a   Fabbri, Muller ^a,b  

^a DEPARTMENT OF MEDICAL ONCOLOGY   (Italy)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CARBOPLATIN; CISPLATIN; EPIDERMAL GROWTH FACTOR RECEPTOR; GEFITINIB; MICRORNA; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN TYROSINE KINASE INHIBITOR; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ARTICLE; BLOOD ANALYSIS; CANCER ADJUVANT THERAPY; CANCER RESISTANCE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; EARLY DIAGNOSIS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE MUTATION; HUMAN; LUNG CANCER; PRIORITY JOURNAL; PROGNOSIS; SPUTUM ANALYSIS; TREATMENT RESPONSE;

HUMANS; LUNG NEOPLASMS; MICRORNAS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 81155127344     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2011.08.004     Document Type: Article

References (29)

1. D.M. Parkin, F. Bray, J. Ferlay, and P. Pisani Global cancer statistics, 2002 CA Cancer J Clin 55 2005 74 108
2. A. Jemal, R. Siegel, J. Xu, and E. Ward Cancer statistics, 2010 CA Cancer J Clin 60 2010 277 300
3. P. Goldstraw, J. Crowley, and K. Chansky The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours J Thorac Oncol 2 2007 706 714
4. Y.E. Miller Pathogenesis of lung cancer: 100 year report Am J Respir Cell Mol Biol 33 2005 216 223
5. D.P. Bartel MicroRNAs: genomics, biogenesis, mechanism, and function Cell 116 2004 281 297
6. C.M. Croce Causes and consequences of microRNA dysregulation in cancer Nat Rev Genet 10 2009 704 714
7. S. Volinia, G.A. Calin, and C.G. Liu A microRNA expression signature of human solid tumors defines cancer gene targets Proc Natl Acad Sci U S A 103 2006 2257 2261
8. N. Yanaihara, N. Caplen, and E. Bowman Unique microRNA molecular profiles in lung cancer diagnosis and prognosis Cancer Cell 9 2006 189 198
9. A. Navarro, R.M. Marrades, and N. Vinolas MicroRNAs expressed during lung cancer development are expressed in human pseudoglandular lung embryogenesis Oncology 76 2009 162 169
10. M. Raponi, L. Dossey, and T. Jatkoe MicroRNA classifiers for predicting prognosis of squamous cell lung cancer Cancer Res 69 2009 5776 5783
11. M. Seike, A. Goto, and T. Okano MiR-21 is an EGFR-regulated anti-apoptotic factor in lung cancer in never-smokers Proc Natl Acad Sci U S A 106 2009 12085 12090
12. D. Lebanony, H. Benjamin, and S. Gilad Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma J Clin Oncol 27 2009 2030 2037
13. J.A. Bishop, H. Benjamin, H. Cholakh, A. Chajut, D.P. Clark, and W.H. Westra Accurate classification of non-small cell lung carcinoma using a novel microRNA-based approach Clin Cancer Res 16 2010 610 619
14. M.T. Landi, Y. Zhao, and M. Rotunno MicroRNA expression differentiates histology and predicts survival of lung cancer Clin Cancer Res 16 2010 430 441
15. N. Rosenfeld, R. Aharonov, and E. Meiri MicroRNAs accurately identify cancer tissue origin Nat Biotechnol 26 2008 462 469
16. X. Chen, Y. Ba, and L. Ma Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases Cell Res 18 2008 997 1006
17. G. Rabinowits, C. Gercel-Taylor, J.M. Day, D.D. Taylor, and G.H. Kloecker Exosomal microRNA: a diagnostic marker for lung cancer Clin Lung Cancer 10 2009 42 46
18. Y. Xie, N.W. Todd, and Z. Liu Altered miRNA expression in sputum for diagnosis of non-small cell lung cancer Lung Cancer 67 2010 170 176
19. L. Yu, N.W. Todd, and L. Xing Early detection of lung adenocarcinoma in sputum by a panel of microRNA markers Int J Cancer 127 2010 2870 2878
20. J. Takamizawa, H. Konishi, and K. Yanagisawa Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival Cancer Res 64 2004 3753 3756
21. S.L. Yu, H.Y. Chen, and G.C. Chang MicroRNA signature predicts survival and relapse in lung cancer Cancer Cell 13 2008 48 57
22. S.K. Patnaik, E. Kannisto, S. Knudsen, and S. Yendamuri Evaluation of microRNA expression profiles that may predict recurrence of localized stage I non-small cell lung cancer after surgical resection Cancer Res 70 2010 36 45
23. J. Voortman, A. Goto, and J. Mendiboure MicroRNA expression and clinical outcomes in patients treated with adjuvant chemotherapy after complete resection of non-small cell lung carcinoma Cancer Res 70 2010 8288 8298
24. Z. Hu, X. Chen, and Y. Zhao Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer J Clin Oncol 28 2010 1721 1726
25. L. Galluzzi, E. Morselli, and I. Vitale miR-181a and miR-630 regulate cisplatin-induced cancer cell death Cancer Res 70 2010 1793 1803
26. G.J. Weiss, L.T. Bemis, and E. Nakajima EGFR regulation by microRNA in lung cancer: correlation with clinical response and survival to gefitinib and EGFR expression in cell lines Ann Oncol 19 2008 1053 1059
27. W.C. Cho, A.S. Chow, and J.S. Au Restoration of tumour suppressor hsa-miR-145 inhibits cancer cell growth in lung adenocarcinoma patients with epidermal growth factor receptor mutation Eur J Cancer 45 2009 2197 2206
28. U. Schaefer, O. Voloshanenko, D. Willen, and H. Walczak TRAIL: a multifunctional cytokine Front Biosci 12 2007 3813 3824
29. M. Garofalo, G. Di Leva, and G. Romano miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation Cancer Cell 16 2009 498 509